ArticleImmunologic research2013

Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).

Christelle Le Dantec et al.PubMed ↗Publisher ↗

No numbers read from the abstract.